Anti-ADAM17 antibody
4
(10 Reviews)
|
(54 Publications)
Anti-ADAM17 antibody (ab39162) is a rabbit polyclonal antibody detecting ADAM17 in Western Blot, IP, IHC-P, ICC/IF. Suitable for Human, Pig, Rat.
- Over 40 publications
- Trusted since 2006
View Alternative Names
CD156b, CSVP, TACE, ADAM17, Disintegrin and metalloproteinase domain-containing protein 17, ADAM 17, Snake venom-like protease, TNF-alpha convertase, TNF-alpha-converting enzyme
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ADAM17 antibody (AB39162)
ab39162 staining human normal colon. Staining is localised to membrane.
Left panel : with primary antibody at 4 ug/ml. Right panel : isotype control.
Sections were stained using an automated system DAKO Autostainer Plus , at room temperature. Sections were rehydrated and antigen retrieved with the Dako 3-in-1 AR buffer EDTA pH 9.0 in a DAKO PT Link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 minutes. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 minutes and detected with Dako Envision Flex amplification kit for 30 minutes. Colorimetric detection was completed with diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be required.
- WB
CiteAb
Western blot - Anti-ADAM17 antibody (AB39162)
Western Blotting using Anti-ADAM17 antibody, ab39162. Publication image from Herrera, B. et al., 2017, Nat Commun, 28084316. Legend direct from paper.
TNFα reduces BMPR-II expression and promotes BMPR-II cleavage in PASMCs.(a,b) BMPR2 mRNA expression, normalized to ACTB, in human dPASMCs (a) and PAECs (b) treated with IL-1β (1 ng ml−1), IL-6 (25 ng ml−1), IL-8 (25 ng ml−1) or TNFα (1 ng ml−1) for 24 h (n=3; Student's t-test). (c,d) Representative immunoblots of BMPR-II expression in human dPASMCs (c) and PAECs (d) treated with TNFα (1 ng ml−1) for 1, 4, 8 or 24 h. Reprobed forα-tubulin to ensure equal loading. The data shown are representative of three experiments. (e) Representative confocal images of immunohistochemical staining for TNFα (turquoise) andαSMA (magenta) in lung sections from control, idiopathic and heritable PAH subjects. Nuclei were counterstained with DAPI (blue). Scale bars, 100 µm. (f) Assessment of right ventricular systolic pressure (RVSP) from Bmpr2+/+, SP-C/Tnf/Bmpr2+/+, Bmpr2+/− and SP-C/Tnf/Bmpr2+/− (n=4 per group) mice. (g) Representative immunoblots of BMPR-II expression in lungs isolated from 8 week old Bmpr2+/+ and SP-C/Tnf/Bmpr2+/+ transgenic mice. Reprobed for β-actin to ensure equal loading (n=4). (h) Representative immunoblots of BMPR-II, ADAM10 and ADAM17 in human dPASMCs transfected with DharmaFECT1 alone (DH1), siADAM10, siADAM17, combined siADAM10+siADAM17 (siADAM10/17) or non-targeting siRNA control (siCP) with or without TNFα (1 ng ml−1) treatment for 24 h. Reprobed forα-tubulin to ensure equal loading. The data shown are representative of three experiments. (i) ELISA measurement of soluble BMPR-II in conditioned media from human dPASMCs transfected with wild-type and mutant 5′-myc-tagged BMPR-II constructs and treated with TNFα (1 ng ml−1) for 24 h (n=3). One-way analysis of variance with post hoc Tukey's for multiple comparisons used in f and i. *P≤0.05, ***P≤0.001. Error bars represent mean±s.e.m. Lower molecular mass BMPR-II is indicated by an arrow.
false
- WB
CiteAb
Western blot - Anti-ADAM17 antibody (AB39162)
Western Blotting using Anti-ADAM17 antibody, ab39162. Publication image from Fröhlich, C. et al., 2015, Nat Commun, 26108729. Legend direct from paper.
Genome-wide screen identifies PACS-2 as an ADAM17 regulator(a) Cellular model system used for the genome-wide siRNA screen. 21,121 individual genes were knocked down using siRNAs and the effects on ADAM17-mediated shedding of AP-HB-EGF were measured by quantifying AP cell-surface staining after PMA stimulation. (b+c) siRNA-transfected AP-HB-EGF HT1080 (b) or AP-HB-EGF HeLa (c) cells were PMA-stimulated, and the cell medium analysed for AP activity. The fold change in AP-HB-EGF release was calculated by setting the unstimulated negative control for each experiment to 1, then normalizing the other raw data to this value, and finally calculating the average of all individual experiments. Data in (b) were compiled from 6 individual experiments and in (c) from 3 individual experiments, each performed in triplicate. (d) AP-HB-EGF MCF-7 cells were siRNA-transfected and stimulated with PMA (left-hand panel) or ionomycin (right-hand panel). Conditioned medium was analysed for AP activity as in (b+c). Data were compiled from 4 individual experiments, each performed in triplicate. In all cases, knockdown was confirmed by western blot. On blots,
denotes a non-specific band. Graphs show mean values ± standard error of the mean (SEM). Data were
analysed by ANOVA. **p<0.01, ***p<0.001, ****p<0.0001.
false
- WB
CiteAb
Western blot - Anti-ADAM17 antibody (AB39162)
Western Blotting using Anti-ADAM17 antibody, ab39162. Publication image from Fröhlich, C. et al., 2015, Nat Commun, 26108729. Legend direct from paper.
Genome-wide screen identifies PACS-2 as an ADAM17 regulator(a) Cellular model system used for the genome-wide siRNA screen. 21,121 individual genes were knocked down using siRNAs and the effects on ADAM17-mediated shedding of AP-HB-EGF were measured by quantifying AP cell-surface staining after PMA stimulation. (b+c) siRNA-transfected AP-HB-EGF HT1080 (b) or AP-HB-EGF HeLa (c) cells were PMA-stimulated, and the cell medium analysed for AP activity. The fold change in AP-HB-EGF release was calculated by setting the unstimulated negative control for each experiment to 1, then normalizing the other raw data to this value, and finally calculating the average of all individual experiments. Data in (b) were compiled from 6 individual experiments and in (c) from 3 individual experiments, each performed in triplicate. (d) AP-HB-EGF MCF-7 cells were siRNA-transfected and stimulated with PMA (left-hand panel) or ionomycin (right-hand panel). Conditioned medium was analysed for AP activity as in (b+c). Data were compiled from 4 individual experiments, each performed in triplicate. In all cases, knockdown was confirmed by western blot. On blots,
denotes a non-specific band. Graphs show mean values ± standard error of the mean (SEM). Data were
analysed by ANOVA. **p<0.01, ***p<0.001, ****p<0.0001.
false
Reactivity data
Product details
Anti-ADAM17 antibody (ab39162) is a rabbit polyclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Pig, Rat samples.
What is the molecular weight of ADAM17?
Anti-ADAM17 (ab39162) specifically detects a band for ADAM17 (UniProt: P78536) at a molecular weight of 93kDa.
Trusted by the scientific community
Anti-ADAM17 (ab39162) was first used in a scientific publication in 2006 and has been cited over 40 times in peer-reviewed journals.
Reviewed by scientists
Anti-ADAM17 (ab39162) has over 5 independent reviews from customers.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The ADAM17 protein regulates a multitude of cellular responses such as inflammation and growth factor signaling. It is not part of a complex but interacts with various substrates in the cell membrane. ADAM17 cleaves precursors to release soluble cytokines and growth factors like tumor necrosis factor-alpha (TNF-alpha) and epidermal growth factor receptor (EGFR) ligands which modulate cell proliferation migration and apoptosis.
Pathways
ADAM17 plays an integral role in both the TNF and EGFR signaling pathways. These pathways are important in maintaining normal cellular homeostasis. ADAM17 interacts with proteins like TNF receptors and ligands of the EGFR family integrating signaling that affects immune response and cell growth. The regulatory function of ADAM17 in these pathways makes it an important target for modulating cellular responses triggered by external stimuli.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (54)
Recent publications for all applications. Explore the full list and refine your search
International journal of oral science 17:18 PubMed40075093
2025
Applications
Unspecified application
Species
Unspecified reactive species
Viruses 16: PubMed39459898
2024
Applications
Unspecified application
Species
Unspecified reactive species
Proteomics 24:e202400076 PubMed39318062
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:14535 PubMed38914585
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 84:2152-2165.e5 PubMed38781971
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular life sciences : CMLS 81:163 PubMed38570362
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of neuroscience : the official journal of the Society for Neuroscience 44: PubMed38418221
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular life sciences : CMLS 81:102 PubMed38409522
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 84:277-292.e9 PubMed38183983
2024
Applications
Unspecified application
Species
Unspecified reactive species
American journal of physiology. Heart and circulatory physiology 326:H270-H277 PubMed37999645
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com